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Discussion
Hypotension and bradycardia are common complications of spinal 
anesthesia. Intraoperative hypotension and bradycardia may lead to 
complications that require additional treatment and increase cost. 
The literature identifies intervention strategies to attenuate spinal-
induced hypotension (SIH) and bradycardia.1 Prophylactic 
administration of ondansetron, a serotonin 5-hydroxytryptamine 
receptor antagonist, prior to spinal anesthesia is associated with 
reduced SIH and bradycardia.1,2,3,4,6
The objective of this scholarly project was to report the practice of 
ondansetron prophylaxis for SIH and bradycardia and the rate of 
rescue interventions in patients who received ondansetron prior to 
spinal anesthesia. 
Figure 2. Descriptive Time Series of Ondansetron Administration for 
SIH and Bradycardia Prophylaxis
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• Retrospective, multi-center observational evidence-based 
practice project conducted at Providence Sacred Heart Medical 
Center (PSHMC) and Providence Holy Family Hospital (PHFH)
• Approved by the PSHMC Clinical Innovation and Research 
Council, and deemed exempt by Providence Health Care 
Institutional Review Board
• Data was retrospectively extracted, de-identified, encrypted, and 
stored in a HIPAA-compliant REDCap database
• Eligibility inclusion criteria: obstetric and orthopedic surgery 
undergoing spinal anesthesia from January 2018 to December 
2019, age 18-90 years old, ondansetron administered prior to 
spinal anesthesia, spinal anesthesia with bupivacaine 0.5% and 
bupivacaine 0.75%
• Exclusion criteria: general anesthesia with ETT/LMA, spinal 
anesthesia medications other than bupivacaine, other surgical 
services
• Univariate and bivariate analyses to report baseline group 
comparability and prophylactic ondansetron relationships
• Multivariable analysis to report independent risk factors
• Multivariate analysis to report descriptive time series
This retrospective EBP project demonstrated a gap in practice with 
the administration of prophylactic ondansetron to attenuate SIH 
and bradycardia across service lines and facilities. 
Rates of prophylactic ondansetron administration prior to spinal 
anesthesia were 42-73% among obstetric surgery. Rates of 
prophylactic ondansetron were 2-12% among orthopedic surgery.
This project is retrospective and observational in nature, which 
cannot account for confounding factors that may affect the results. 
Limitations of this project include the inability to differentiate the 
use of ondansetron for prophylactic SIH or post-operative nausea 
and vomiting. Other SIH and bradycardia prevention strategies may 
have also been performed but not described in this project (such as 
fluid pre-loading or co-loading, prophylactic low dose 
phenylephrine infusion, or prophylactic vasopressor prior to spinal 
anesthesia). This project suggests EBP improvements for the 
utilization of ondansetron to attenuate SIH and bradycardia. 
Table 2. Proportion of Patients Treated with Rescue Medications 
after Ondansetron Prophylaxis
Table 1. Comparison of Baseline Demographics and Characteristics (N=3153)
Providence Sacred Heart 
Medical Center









Variable n % n % n % n %
Male 0 0 533 46 0 0 259 48
Female 1245 100 636 54 200 100 280 52
ASA* I 12 1 24 2 11 6 5 1
II 863 69 686 59 137 69 247 46
III 331 27 389 33 30 15 229 42
IV 4 0 21 2 0 0 9 2
Variable Mean SD* Mean SD Mean SD Mean SD
Age 
(years)
31 6 67 11 31 5 66 11
BMI 
(kg/m2)
34 8 29 5 35 7 31 6
Median IQR* Median IQR Median IQR Median IQR
Case Duration 
(min)






















JANUARY 2018 TO DECEMBER 2019





*ASA=American Society of Anesthesiologist Physical Status Classification System; SD=standard deviation; 
IQR=interquartile range (25th-75th)
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337 48% 1.06 0.95-1.19 0.27
229 35% 0.94 0.84-1.05 0.28
Orthopedic Yes
No
105 58% 1.10 0.96-1.25 0.20





109 14% 1.01 0.78-1.30 0.94
91 14% 1.09 0.84-1.42 0.49
Orthopedic Yes
No
70 38% 1.13 0.82-1.12 0.25





113 14% 0.92 0.72-1.18 0.53
103 16% 1.08 0.85-1.38 0.53
Orthopedic Yes
No
14 8% 0.57 0.34-0.97 0.03
156 13% 1.64 0.99-2.70 0.05
*IVB=Intravenous Bolus
Obstetric and Orthopedic 
Spinal Anesthesia Cases 
(N=3157)
Providence Sacred 


















error in EMR 
(n=4)
Figure 1. Flow Diagram of Patient Selection
